Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Disease Outbreaks | 10 | 2021 | 27595 | 0.66 | Why? |
| Ebolavirus | 2 | 2019 | 834 | 0.59 | Why? |
| Ships | 2 | 2021 | 1046 | 0.58 | Why? |
| Population Density | 1 | 2020 | 694 | 0.56 | Why? |
| Measles | 2 | 2018 | 608 | 0.51 | Why? |
| Severe Dengue | 1 | 2014 | 135 | 0.48 | Why? |
| Basic Reproduction Number | 3 | 2020 | 2676 | 0.46 | Why? |
| Hemorrhagic Fever, Ebola | 2 | 2019 | 1475 | 0.44 | Why? |
| Coronavirus Infections | 14 | 2020 | 253789 | 0.29 | Why? |
| Camelus | 1 | 2014 | 1425 | 0.29 | Why? |
| Asymptomatic Infections | 2 | 2020 | 7218 | 0.27 | Why? |
| Contact Tracing | 2 | 2021 | 8448 | 0.26 | Why? |
| Age Distribution | 4 | 2021 | 3567 | 0.25 | Why? |
| Sex Distribution | 2 | 2021 | 2083 | 0.25 | Why? |
| Republic of Korea | 4 | 2016 | 5858 | 0.24 | Why? |
| Oceans and Seas | 1 | 2021 | 73 | 0.22 | Why? |
| Travel | 1 | 2020 | 7220 | 0.22 | Why? |
| Democratic Republic of the Congo | 2 | 2019 | 500 | 0.21 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.21 | Why? |
| Seafood | 1 | 2020 | 103 | 0.20 | Why? |
| Models, Statistical | 3 | 2020 | 5312 | 0.18 | Why? |
| Tegafur | 1 | 2017 | 4 | 0.18 | Why? |
| Oxonic Acid | 1 | 2017 | 4 | 0.18 | Why? |
| Food Services | 1 | 2020 | 156 | 0.18 | Why? |
| Models, Theoretical | 3 | 2021 | 6659 | 0.17 | Why? |
| Birth Rate | 1 | 2018 | 137 | 0.17 | Why? |
| Models, Biological | 1 | 2014 | 4907 | 0.16 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.16 | Why? |
| Cross Infection | 2 | 2016 | 8675 | 0.16 | Why? |
| Chile | 1 | 2021 | 1095 | 0.16 | Why? |
| Deoxycytidine | 1 | 2017 | 116 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Probability | 1 | 2020 | 923 | 0.15 | Why? |
| Peru | 1 | 2020 | 1010 | 0.15 | Why? |
| Risk | 2 | 2021 | 5288 | 0.15 | Why? |
| Survival Analysis | 2 | 2020 | 7592 | 0.14 | Why? |
| Influenza Pandemic, 1918-1919 | 1 | 2018 | 339 | 0.14 | Why? |
| Spatio-Temporal Analysis | 1 | 2020 | 1182 | 0.13 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2016 | 8843 | 0.13 | Why? |
| Virulence | 1 | 2020 | 2172 | 0.12 | Why? |
| Public Health Practice | 1 | 2021 | 945 | 0.12 | Why? |
| Humans | 26 | 2021 | 930598 | 0.12 | Why? |
| Cross Protection | 1 | 2014 | 373 | 0.12 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.12 | Why? |
| Infant | 5 | 2021 | 30274 | 0.11 | Why? |
| Child, Preschool | 6 | 2021 | 36283 | 0.11 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2017 | 2984 | 0.11 | Why? |
| Japan | 3 | 2020 | 6653 | 0.11 | Why? |
| Infant, Newborn | 3 | 2021 | 23105 | 0.10 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.10 | Why? |
| Antibody-Dependent Enhancement | 1 | 2014 | 413 | 0.10 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.10 | Why? |
| China | 4 | 2020 | 50654 | 0.10 | Why? |
| Adenocarcinoma | 1 | 2017 | 651 | 0.10 | Why? |
| Public Health | 3 | 2021 | 16359 | 0.10 | Why? |
| Pancreatic Neoplasms | 1 | 2017 | 609 | 0.10 | Why? |
| Health Personnel | 1 | 2019 | 29646 | 0.09 | Why? |
| Epidemics | 2 | 2019 | 6407 | 0.09 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.09 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.09 | Why? |
| Influenza, Human | 3 | 2018 | 10779 | 0.09 | Why? |
| Arizona | 2 | 2018 | 416 | 0.08 | Why? |
| Antibodies, Neutralizing | 1 | 2014 | 25288 | 0.08 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1573 | 0.08 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.08 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.07 | Why? |
| Coronavirus | 2 | 2014 | 18339 | 0.07 | Why? |
| Infectious Disease Incubation Period | 1 | 2012 | 1033 | 0.07 | Why? |
| Multivariate Analysis | 1 | 2015 | 5440 | 0.07 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.07 | Why? |
| Child | 4 | 2021 | 70012 | 0.07 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.07 | Why? |
| Male | 10 | 2021 | 367725 | 0.07 | Why? |
| Female | 10 | 2021 | 380317 | 0.06 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.06 | Why? |
| Quarantine | 2 | 2021 | 18418 | 0.06 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.06 | Why? |
| Aged | 7 | 2021 | 215776 | 0.06 | Why? |
| History, 20th Century | 2 | 2018 | 1282 | 0.06 | Why? |
| Antibodies, Viral | 1 | 2014 | 51949 | 0.05 | Why? |
| Adult | 6 | 2021 | 244371 | 0.05 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Genes, Fungal | 1 | 1995 | 21 | 0.04 | Why? |
| Time | 1 | 2019 | 631 | 0.04 | Why? |
| Death Certificates | 1 | 2017 | 130 | 0.04 | Why? |
| Indians, North American | 1 | 2018 | 195 | 0.04 | Why? |
| Italy | 1 | 2020 | 38444 | 0.04 | Why? |
| Nucleotidyltransferases | 1 | 1995 | 77 | 0.04 | Why? |
| Saccharomyces cerevisiae | 1 | 1995 | 339 | 0.03 | Why? |
| Measles Vaccine | 1 | 2017 | 301 | 0.03 | Why? |
| Vaccination | 1 | 2019 | 19050 | 0.03 | Why? |
| Neoadjuvant Therapy | 1 | 2017 | 554 | 0.03 | Why? |
| Spatial Analysis | 1 | 2018 | 878 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Mexico | 1 | 2021 | 2787 | 0.03 | Why? |
| Cities | 1 | 2021 | 4937 | 0.02 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2012 | 12361 | 0.02 | Why? |
| Drug Combinations | 1 | 2017 | 3852 | 0.02 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.02 | Why? |
| Animals | 1 | 2014 | 78931 | 0.02 | Why? |
| Retrospective Studies | 1 | 2016 | 105322 | 0.02 | Why? |
| Cause of Death | 1 | 2017 | 4823 | 0.02 | Why? |
| Hong Kong | 1 | 2012 | 3361 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Bayes Theorem | 1 | 2012 | 3237 | 0.02 | Why? |
| Saudi Arabia | 1 | 2012 | 4423 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2018 | 8495 | 0.01 | Why? |
| Social Media | 1 | 2021 | 5798 | 0.01 | Why? |
| Patient Isolation | 1 | 2012 | 3182 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Diagnosis, Differential | 1 | 2012 | 7220 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Chromosomes, Fungal | 1 | 1995 | 2 | 0.01 | Why? |
| Restriction Mapping | 1 | 1995 | 55 | 0.01 | Why? |
| Genes, Recessive | 1 | 1995 | 35 | 0.01 | Why? |
| Schizosaccharomyces | 1 | 1995 | 9 | 0.01 | Why? |
| Mutation | 1 | 1995 | 12376 | 0.01 | Why? |
| Sequence Homology, Amino Acid | 1 | 1995 | 945 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2012 | 22971 | 0.01 | Why? |
| DNA Primers | 1 | 1995 | 1170 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 1995 | 3198 | 0.01 | Why? |
| Open Reading Frames | 1 | 1995 | 1898 | 0.01 | Why? |
| Base Sequence | 1 | 1995 | 3581 | 0.01 | Why? |
| Kinetics | 1 | 1995 | 3238 | 0.01 | Why? |
| Temperature | 1 | 1995 | 2305 | 0.00 | Why? |
| Amino Acid Sequence | 1 | 1995 | 6049 | 0.00 | Why? |
| Genotype | 1 | 1995 | 4697 | 0.00 | Why? |
| Hospitalization | 1 | 2012 | 54280 | 0.00 | Why? |
| Polymerase Chain Reaction | 1 | 1995 | 6740 | 0.00 | Why? |
Mizumoto's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(131)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_